Advertisement

Topics

Companies Related to "Trial of Maraviroc (UK-427,857) in Combination With Optimized Background Therapy Versus Optimized Background Therapy Alone for the Treatment of HIV-1 Infected Subjects" [Most Relevant Company Matches] RSS

01:28 EST 23rd February 2019 | BioPortfolio

Here are the most relevant search results for "Trial of Maraviroc (UK-427,857) in Combination With Optimized Background Therapy Versus Optimized Background Therapy Alone for the Treatment of HIV-1 Infected Subjects" found in our extensive corporate database of over 50,000 company records.

Showing "Trial Maraviroc Combination With Optimized Background Therapy Versus" Companies 1–25 of 2,100+

Relevant

Biothera

Biothera, a privately held U.S. biotechnology company, is developing Imprime PGG, a late clinical stage biologic that modulates the immune response to cancer. Data from the most recent randomized phase 2 study of Imprime PGG in first line non-squamous non-small cell lung cancer (NSCLC) was featured as a late-breaking abstract in the Immunotherapy of Cancer...


Oncolytics Biotech Inc.

Oncolytics Biotech Inc. was formed in 1998 to develop its proprietary product, REOLYSIN®, as a potential therapeutic for a wide variety of human cancers. Oncolytics has completed five clinical trials with REOLYSIN® in Canada and the U.K. and is currently conducting four Phase I or Phase I/II REOLYSIN® trials in the U.K. and the U.S. The company also has permission to commence a Phase II combina...

NightstaRx Limited

Nightstar is a leading retinal gene therapy company focused on developing and commercializing novel, potentially curative one-time treatments for patients suffering from rare inherited retinal diseases that would otherwise progress to blindness, and for which there are no other treatment options. Nightstar’s lead program, NSR-REP1, is being developed ...


Soligenix, Inc.

Soligenix, Inc. (Soligenix) is a late-stage biopharmaceutical company developing products to treat life-threatening side effects of cancer treatments and serious gastrointestinal diseases, and vaccines for certain bioterrorism agents. Soligenix's lead product, orBec(®) (oral beclomethasone dipropionate or BDP), is a potent, locally acting corticosteroid being developed for the treatment of acute ...

NeoMatrix, LLC

Based in Irvine, Calif., NeoMatrix© develops innovative devices that allow women and their doctors to promote optimal breast health. The company's premier product, the HALO Breast Pap Test System, is the first fully automated, noninvasive breast cancer risk assessment tool designed for use in the primary care office setting. The System has been FDA cleared for the collection of nipple aspirate fl...

Constant Therapy

Free Trial Download and Video Demo

Therapy Source, Inc.

Therapy Source, a premier therapy staffing provider, offers highly qualified speech, occupational, physical, psychological and related therapy services to educational and healthcare organizations. For more information on Therapy Source, visit www.txsource.net or call toll free at 866-783-5301.

Asterias Biotherapeutics, Inc.

Asterias Biotherapeutics is a subsidiary of BioTime, Inc., whose mission is to acquire and develop best in class cell therapy product candidates. Our first acquisition was the stem cell assets of Geron Corporation, which was completed on October 1, 2013. That acquisition includes Geron’s entire cell therapy intellectual property portfolio, existing co...

Hanmi Pharmaceutical co., Ltd.

Hanmi Pharmaceutical is a Korea-based pharmaceutical company. The Company invests over 20 percent of its sales in R&D and has over 20 programs consisting of the novel long acting biologics including weekly Insulin, weekly to monthly GLP-1, and their combination for diabetes and obesity (collectively referred as Quantum Project), the novel targeted anti-can...

INHERINET

INHERINET (Gene Therapy of Hematopoietic Stem Cells for Inherited Diseases), an initiative founded by seven European research institutions, accumulates the expertise of biomedical scientists who have a strong background in the development of all platform technologies required for successful gene therapy:State-of -the-art design and production of retroviral and lentiviral gene transfer vectors Basi...

Dynavax Technologies

Dynavax Technologies Corporation discovers, develops, and intends to commercialize innovative therapeutic products to treat and prevent infectious diseases, allergies, and cancer. Our versatile, proprietary approaches alter specific immune responses by activating a unique receptor called Toll-Like Receptor 9 (TLR9) found on certain immune system cells. To target TLR9, we are using immunostimulat...

Trial By Fire Solutions

Trial By Fire Solutions is a global leader in web-based clinical trial management solutions and develops innovative applications to improve planning, execution and tracking of clinical studies. Since the release of its SimpleCTMS product, Trial By Fire Solutions has been providing affordable eClinical solutions to teams of all sizes.

Provisio, Inc

Headquartered in Nashville, TN, Provisio, Inc. develops technologies and services that enhance clinical trial processes. Its flagship solution, iTrials, automates and streamlines the way drug trial candidates are identified, notified and enrolled. iTrials breaks the traditional paradigm associated with lengthy and costly clinical trial enrollment. Leveraging iTrials "unique-to-industry" data wareh...

Vicus Therapeutics, LLC

Vicus Therapeutics is a biopharmaceutical company dedicated to bringing breakthrough therapies to patients with cancer. Vicus' lead investigational therapy, VT-122, is a combination of etodolac and propranolol. VT-122 showed positive results in a Phase 2 clinical trial of lung cancer patients and is currently being evaluated in a Phase 2 clinical trial of liver cancer patients receiving Nexavar ...

Carbylan BioSurgery, Inc.

Carbylan (www.carbylan.com) was founded in 2005 to develop and market medical devices and device/drug combination products based on novel chemically engineered polymer systems incorporating hyaluronic acid, a well-known polysaccharide widely present in the human body. Its initial market focus is therapeutic medical devices and combination products to treat...

Gene Therapy Systems (GTS)

Gene Therapy Systems, Inc. (GTS) designs, develops and commercializes gene therapy products along with other molecular biological reagents for scientists specializing in gene therapy research. GTS is the only company in the biotechnology reagent business that primarily focuses on gene therapy related products.

Trial Acceleration Institute, Inc.

Trial Acceleration Institute collaborates with the entire spectrum of clinical trial stakeholders to improve study cycle times. Assisting stakeholders with actionable resolutions to their specific cycle time challenges (from protocol feasibility to patient retention) via the identification and initiation of best-of-class, third-party solutions is the primary mission of Trial Acceleration Institute...

MindFrame Inc.

MindFrame Inc. is a pioneer in developing optimized technologies for patients experiencing ischemic stroke. The breakthrough MindFrame Therapy Solutions portfolio comprises some of the most advanced device design technology that delivers exceptional rapid flow restoration and clot extraction intended to help clinicians provide improved clinical outcomes fo...

Merchants Information Solutions

Merchants Information Solutions, the exclusive provider of the Merchants Pre-employment Integrity Test which is proven to reduce worker' compensation rates an average of 60%, is a national leader in background screening for employers and residential communities as well as a leader in ID Theft Restoration Affinity programs. Honored to have as company national spokespersons Jerry Colangelo and Harve...

The Dent Law Firm

Dwain Dent found The Dent Law Firm in 1990. Dent has been recognized as a Texas Superlawyer by Texas Monthly Magazine and as one of the Top 100 Trial Lawyers by the American Trial Lawyers Association. He is board certified in personal injury trial work by the Texas Board of Legal Specialization, the State Bar of Texas and the National Board of Trial Advocacy.

MindFrame, Inc.

MindFrame Inc. is a pioneer in developing optimized technologies for patients experiencing ischemic stroke. The breakthrough MindFrame Therapy Solutions portfolio comprises some of the most advanced device design technology that delivers exceptional rapid flow restoration and clot extraction intended to help clinicians provide improved clinical outcomes fo...

Valentis

Valentis is a biotechnology company that was engaged in the development of innovative products for peripheral arterial disease (PAD), a large and unsatisfied market. On July 11, 2006 Valentis announced that no statistically significant difference was seen in the primary endpoint or any of the secondary endpoints in its Phase IIb clinical trial of VLTS 934 in PAD. The primary efficacy endpoint in t...

ProActive Sports Therapy

ProActive Sports Therapy clinic is a new 5,000 square foot, state-of-the-art facility located in Montclair, NJ. The facility offers anyone seeking physical and sports therapy in the New York metropolitan area with a full range of top rate physical therapy services from pre/post surgical rehabilitation to pain management, therapeutic massage therapy, chiropractic care, acupuncture and strength cond...

Amorcyte, Inc.

Amorcyte is a privately held biotechnology company developing cell therapy products to treat cardiovascular disease. Its lead product AMR-001, for the prevention of major adverse cardiac events following acute myocardial infarction (AMI), has completed Phase I clinical trials demonstrating feasibility, safety and biologic activity at a threshold dose. This is the first stem cell trial in AMI eve...

Reverse Therapy UK Limited

John Eaton is the Founder of Reverse Therapy and has been innovating in the field of therapy since 1988. Since 1996 he has been steadily developing the ideas, techniques and principles that, collectively, he named 'Reverse Therapy' in 2002.He has brought together a unique blend of insights drawn from Bodymind healing techniques, Symptom-focused therapy and Psychobiology that forms a powerful appli...


More From BioPortfolio on "Trial of Maraviroc (UK-427,857) in Combination With Optimized Background Therapy Versus Optimized Background Therapy Alone for the Treatment of HIV-1 Infected Subjects"

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks